EUROPEAN VENTURE FUNDING FOR DEEP TECH

Our clients tackle the most pressing issues of our time.

We get them the funding they need to succeed.

We secure institutional capital for European breakthrough innovations.

The full capital stack. Non-dilutive grants, equity, and venture debt for deep-tech ventures—from €2.5M to €50M—deployed through Europe's most competitive institutional programs.

High Conviction. Investor-Grade Standards. We operate on a strict, limited, selective mandate model. Every engagement is built as a rigorous investment case, from technical validation to signature.

Absolute Alignment. No upfront fees. No retainers. We are compensated only when your funding settles.

One adviser, from first institutional round to industrial scale.

We work across the four European instruments that fund deep tech at scale.

DEVELOPMENT

TRL3 to TRL5

Turns research results into a validated technology and business case.

€2,5M Grant

Seed

EIC Transition

MARKET ENTRY

TRL6 to TRL9

EIC Accelerator

€12,5M Grant & Equity

Series A/B

Europe's flagship deep-tech programme, for market entry and early scale-up.

SCALING

Any TRL

€10M - €30M Equity

Series B/C

Step ScaleUp

For proven technologies scaling into industrial deployment with commercial traction.

EXPANSION

TRL9 +

Finances first-of-a-kind plants and capacity expansion with minimal dilution.

€15M to €50M Debt

Series C/D

EIB Venture Debt

Deep Science, Strong Patents.

We take mandates from ventures built on scientific discoveries, with defensible IP and a credible path to industrial scale.

INDUSTRIAL TRANSFORMATION

Alt. Energy Production & Storage, Clean-Tech, Climate-Tech, Novel Foods, Agriculture

STRATEGIC AUTONOMY

New Space & Aeronautics, AI, Quantum Computing, Dual-use, Cyber Security, Semiconductors, Defence

ADVANCING HUMAN HEALTH

Cell & Gene Therapies, Infectious Diseases, Clinical Trials, Drug Development

No upfront fees. No retainers.

We are compensated only when your funding settles — aligning our incentives with your success.

Every mandate follows the same four stages. One team stays with you throughout.

1. Assess

We review your technology, IP and freedom-to-operate, team, financing and market. We engage only where we identify a credible path to success.

2. Build

We write the application as an investment case: technical work plan, business plan, financial model, impact and risk analysis.

3. Defend

We prepare your team for the jury: pitch, Q&A rehearsals and every number stress-tested before you enter the room.

4. Close

For equity and debt, we support you through due diligence, term-sheet negotiation and contracting, until the funds arrive.

Portfolio Clients

CERABYTE (DE) - €17,5M

Ceramic based data storage to minimize electronic waste and reduce the energy consumption of data centers worldwide.
WOODOO (FR) - €10,5M

Transforming wood into high-performance alternative to steel, aluminum, and concrete for construction.
BLYKALLA (SWE) - €17,5M

Small nuclear modular reactors for clean energy.
EVEROX (NL) - €12,5M

Everox upcycles concrete waste, replacing raw materials with circular concrete.
ALTRATECH (IE) - €17,5M

Instant portable molecular testing technology.
FIBRIANT (NL) - €16,5M

Recombinant manufacturing of human fibrinogen & thrombin.
CHROMAFORA (SWE) - €22,5M

Filtration technology to remove PFAS and heavy metals from landfills and our water supply.
REVERION (DE) - €12,5M

Reversible high-temperature fuel cells to efficiently convert biogas, hydrogen, or methane into electricity or vice versa
INFINITE ROOTS (DE) - €17,5M

Precision fermentation to develop plant based protein derivatives using mycelium.
GAFT (NL) - €10,5M

End-to-end solution to sustainable aviation fuel from carbon dioxide without fossil fuels.
XENOMATIX (BE) - €8,5M

True solid state LiDAR for autonomous driving
TOPOSENS (DE) - €3,5M

3D Ultrasonic echolocation technology for colision avoidance.
SPHERICAL SYS. (NL) - €4M

Advanced chip architecture for satellite industry applications.
CELLBOX (DE) - €12,5M

Portable CO2 incubator for the transport of biological cells at room temperature.
RNHALE (DE) - €2,5M

Inhalable RNA-based therapeutics.
ESENCIA (DE) - €4,5M

Next-generation alternative protein through precision fermentation.
ECOLYTE (AT) €2,5M

Sustainable energy storage through bio-based electrolytes and paper-derived membranes that replace toxic, mined materials.
FYTEKO (BE) - €2,8M

Biomolecules for plant resiliance and adaptation to the effects of climate change.
LITHOS (AT) - €5,6M

Bio-based pest control solutions, using innovative pheromone technologies to protect crops without harming the environment.